<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://predicine.com/wp-sitemap.xsl" ?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"><url><loc>https://predicine.com/2019/05/31/predicineatlas-600-gene-liquid-biopsy-panel-to-accelerate-io-clinical-trials/</loc><lastmod>2019-11-07T01:11:09+00:00</lastmod></url><url><loc>https://predicine.com/2018/04/30/predicine-launches-predicineatlas-a-600-gene-blood-based-tmb-panel-to-accelerate-immuno-oncology-clinical-trials/</loc><lastmod>2019-11-07T00:54:46+00:00</lastmod></url><url><loc>https://predicine.com/2019/09/27/2019-esmo-congress/</loc><lastmod>2019-11-14T02:07:58+00:00</lastmod></url><url><loc>https://predicine.com/2019/05/10/predicine-partners-with-fmd-to-accelerate-biomarker-driven-clinical-trials-and-regulatory-approvals-in-the-u-s-and-china/</loc><lastmod>2019-11-07T00:50:06+00:00</lastmod></url><url><loc>https://predicine.com/2018/12/03/congruence-study-between-two-ctdna-liquid-biopsy-testing-in-mbc-patients-and-prognostic-value-in-combination-with-ctcs-investigators-to-report-at-sabcs-2018/</loc><lastmod>2019-11-07T00:50:56+00:00</lastmod></url><url><loc>https://predicine.com/2018/10/18/predicine-establishes-dual-cap-accreditation-for-its-genomic-sequencing-laboratories-in-us-and-china-to-support-global-clinical-trials/</loc><lastmod>2019-11-07T00:52:08+00:00</lastmod></url><url><loc>https://predicine.com/2018/09/27/predicine-receives-cap-accreditation-for-its-precision-cancer-testing-laboratory-in-shanghai/</loc><lastmod>2019-11-14T02:10:20+00:00</lastmod></url><url><loc>https://predicine.com/2018/09/20/predicine-and-flagship-biosciences-partner-to-support-global-biomarker-development/</loc><lastmod>2019-11-07T00:52:43+00:00</lastmod></url><url><loc>https://predicine.com/2018/08/22/predicine-and-kintor-pharma-to-present-ctdna-ctrna-biomarker-data-for-phi-ii-clinical-trial-in-mcrpc-at-esmo-2018/</loc><lastmod>2019-11-07T00:53:50+00:00</lastmod></url><url><loc>https://predicine.com/2018/07/03/predicine-and-kintor-pharmaceuticals-collaborate-on-precision-oncology-clinical-trials-and-companion-diagnostics-development/</loc><lastmod>2019-11-07T00:54:17+00:00</lastmod></url><url><loc>https://predicine.com/2018/04/16/predicine-closes-series-a-financing-totaling-13-5m/</loc><lastmod>2019-11-07T00:55:14+00:00</lastmod></url><url><loc>https://predicine.com/2019/01/05/interview-with-shidong-jia-of-predicine/</loc><lastmod>2019-11-14T19:11:20+00:00</lastmod></url><url><loc>https://predicine.com/2018/06/03/precision-clinical-trials-in-io/</loc><lastmod>2019-11-07T01:09:53+00:00</lastmod></url><url><loc>https://predicine.com/2017/06/03/liquid-biopsy-to-accelerate-patient-enrollment-in-clinical-trials/</loc><lastmod>2019-11-07T01:09:22+00:00</lastmod></url><url><loc>https://predicine.com/2017/02/13/tumor-biomarkers-guide-immunotherapy/</loc><lastmod>2019-11-07T00:58:44+00:00</lastmod></url><url><loc>https://predicine.com/2019/09/19/2019-chinese-society-of-clinical-oncology-annual-meeting/</loc><lastmod>2019-11-14T02:05:21+00:00</lastmod></url><url><loc>https://predicine.com/2019/08/20/2019-next-generation-dx-summit/</loc><lastmod>2019-11-14T02:07:34+00:00</lastmod></url><url><loc>https://predicine.com/2019/05/31/2019-american-society-of-clinical-oncology-annual-meeting/</loc><lastmod>2019-11-14T02:07:03+00:00</lastmod></url><url><loc>https://predicine.com/2019/03/31/2019-american-society-of-cancer-research-annual-meeting/</loc><lastmod>2019-11-14T02:06:28+00:00</lastmod></url><url><loc>https://predicine.com/2018/10/23/2018-esmo-congress/</loc><lastmod>2019-11-14T02:01:32+00:00</lastmod></url><url><loc>https://predicine.com/2020/01/07/predicine-and-merck-kgaa/</loc><lastmod>2020-01-08T05:59:54+00:00</lastmod></url><url><loc>https://predicine.com/2019/12/02/predicine-translational-research-award-at-harvard-medical-schools-ness-2020/</loc><lastmod>2019-12-02T22:07:00+00:00</lastmod></url><url><loc>https://predicine.com/2020/01/13/aacr-advances-in-liquid-biopsy-2020/</loc><lastmod>2020-01-23T00:21:24+00:00</lastmod></url><url><loc>https://predicine.com/2020/02/12/asco-gu-2020/</loc><lastmod>2020-02-13T00:15:24+00:00</lastmod></url><url><loc>https://predicine.com/2020/02/28/molecular-med-tri-con-2020/</loc><lastmod>2020-02-28T23:47:34+00:00</lastmod></url><url><loc>https://predicine.com/2020/05/04/predicine-covid-19-message/</loc><lastmod>2020-05-07T22:10:44+00:00</lastmod></url><url><loc>https://predicine.com/2020/05/14/asco20-virtual/</loc><lastmod>2020-05-14T22:43:40+00:00</lastmod></url><url><loc>https://predicine.com/2020/06/18/predicine-presents-methylation-liquid-biopsy-data-at-aacr20-virtual-meeting/</loc><lastmod>2020-06-18T19:03:45+00:00</lastmod></url><url><loc>https://predicine.com/2020/09/22/esmo-virtual-congress-2020/</loc><lastmod>2020-09-22T01:54:05+00:00</lastmod></url><url><loc>https://predicine.com/2020/10/14/predicine-to-host-liquid-biopsy-symposium-alongside-merck-kgaa-and-washington-university-on-mrd-and-early-cancer-detection-at-the-2020-islb-virtual-congress/</loc><lastmod>2021-01-07T00:08:01+00:00</lastmod></url><url><loc>https://predicine.com/2020/10/29/predicine-and-epic-sciences-jointly-announce-strategic-partnership-to-expand-liquid-biopsy-offerings-to-biopharmaceutical-partners/</loc><lastmod>2020-11-14T02:12:39+00:00</lastmod></url><url><loc>https://predicine.com/2021/01/11/predicine-selected-as-top-5-liquid-biopsy-startups-in-oncology/</loc><lastmod>2021-01-11T19:53:19+00:00</lastmod></url><url><loc>https://predicine.com/2021/01/18/predictive-value-of-plasma-tmb-presented-at-2021-asco-gi/</loc><lastmod>2021-01-26T22:07:06+00:00</lastmod></url><url><loc>https://predicine.com/2021/02/11/predicine-to-present-data-that-highlight-comprehensive-liquid-biopsy-solutions-at-2021-asco-gu-cancers-symposium/</loc><lastmod>2021-02-14T21:09:10+00:00</lastmod></url><url><loc>https://predicine.com/2021/03/03/webinar-urine-based-ngs-liquid-biopsy-applications-in-bladder-cancer-march-23-1pm-est/</loc><lastmod>2021-04-08T21:05:31+00:00</lastmod></url><url><loc>https://predicine.com/2021/04/06/webinar-liquid-based-detection-of-copy-number-variations-cnvs-in-cancer/</loc><lastmod>2021-04-09T20:54:29+00:00</lastmod></url><url><loc>https://predicine.com/2021/06/10/aacr-recap-updates-in-liquid-biopsy-webinar/</loc><lastmod>2021-06-10T23:34:11+00:00</lastmod></url><url><loc>https://predicine.com/2021/05/13/new-study-demonstrates-the-clinical-utility-of-predicine-liquid-biopsy-assay-to-detect-copy-number-loss-in-prostate-cancer/</loc><lastmod>2021-05-18T20:11:15+00:00</lastmod></url><url><loc>https://predicine.com/2021/09/01/new-studies-demonstrate-the-clinical-application-of-predicines-liquid-biopsy-assay-to-detect-gene-copy-number-loss-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2021-09-01T20:59:55+00:00</lastmod></url><url><loc>https://predicine.com/2021/09/14/webinar-transforming-global-clinical-trials-with-liquid-biopsy-and-cdx-solutions/</loc><lastmod>2021-09-15T00:30:39+00:00</lastmod></url><url><loc>https://predicine.com/2021/10/06/recent-study-in-the-journal-of-urology-shows-predicinecare-urine-based-liquid-biopsy-test-provides-non-invasive-molecular-profiling-for-patients-with-bladder-cancer/</loc><lastmod>2021-10-06T17:46:34+00:00</lastmod></url><url><loc>https://predicine.com/2021/10/06/predicine-recently-presented-2-data-abstracts-at-the-2021-esmo-conference/</loc><lastmod>2021-10-06T17:49:23+00:00</lastmod></url><url><loc>https://predicine.com/2021/10/21/symposium-predicine-to-present-at-the-annual-international-society-of-liquid-biopsy-islb-congress/</loc><lastmod>2021-10-21T22:52:48+00:00</lastmod></url><url><loc>https://predicine.com/2021/12/22/predicine-appoints-linh-h-le-as-new-chief-financial-officer/</loc><lastmod>2021-12-22T07:57:48+00:00</lastmod></url><url><loc>https://predicine.com/2022/01/04/predicine-appoints-dr-dennis-merkle-as-chief-executive-officer-of-predicine-europe/</loc><lastmod>2022-01-18T17:33:15+00:00</lastmod></url><url><loc>https://predicine.com/2022/01/19/predicine-appoints-clint-webb-as-new-general-cousel-to-support-its-international-expansion/</loc><lastmod>2022-01-20T18:57:52+00:00</lastmod></url><url><loc>https://predicine.com/2022/02/16/predicine-to-present-six-studies-at-2022-asco-gu-annual-conference/</loc><lastmod>2022-02-16T16:39:22+00:00</lastmod></url><url><loc>https://predicine.com/2022/04/11/predicine-expands-its-footprint-in-the-greater-chicago-area-to-better-serve-their-patients-by-increasing-daily-capacity-and-faster-turnaround-time/</loc><lastmod>2022-05-03T17:08:50+00:00</lastmod></url><url><loc>https://predicine.com/2022/04/11/predicine-to-attend-2022-aacr-conference-in-new-orleans-to-highlight-the-launch-of-predicinebeacon-a-novel-tissue-agnostic-actionable-assay-for-minimal-residual-disease-mrd-detection-and-th/</loc><lastmod>2022-05-03T17:08:34+00:00</lastmod></url><url><loc>https://predicine.com/2022/05/13/predicine-liquid-biopsy-outperforms-four-other-leading-ctdna-ngs-tests-in-a-study-led-by-bristol-myers-squibb/</loc><lastmod>2022-05-15T19:02:04+00:00</lastmod></url><url><loc>https://predicine.com/2022/07/25/predicine-expands-its-nationwide-covid-19-testing-capability-through-the-recent-fda-eua-authorization-of-predicine-sars-cov-2-rt-pcr-test-and-self-collection-kit/</loc><lastmod>2022-07-29T22:23:38+00:00</lastmod></url><url><loc>https://predicine.com/2022/08/08/predicine-expands-to-europe-with-the-recently-launched-ce-marked-cfdna-assay-predicinecaretm-for-genomic-profiling-in-blood-and-urine/</loc><lastmod>2022-08-09T16:02:54+00:00</lastmod></url><url><loc>https://predicine.com/2022/09/08/predicine-to-present-new-data-at-esmo-2022-demonstrating-the-utility-of-its-portfolio-of-liquid-biopsy-tests-for-cancer-patients/</loc><lastmod>2022-09-08T20:36:17+00:00</lastmod></url><url><loc>https://predicine.com/2022/09/20/predicines-liquid-biopsy-next-generation-sequencing-ngs-assay-is-granted-breakthrough-device-designation-by-u-s-food-and-drug-administration/</loc><lastmod>2022-11-11T17:22:57+00:00</lastmod></url><url><loc>https://predicine.com/2024/04/03/predicine-to-present-15-liquid-biopsy-studies-at-aacr-2024/</loc><lastmod>2024-04-04T02:01:52+00:00</lastmod></url><url><loc>https://predicine.com/2024/05/22/predicine-to-present-9-liquid-biopsy-studies-at-asco-2024/</loc><lastmod>2024-05-25T08:33:10+00:00</lastmod></url><url><loc>https://predicine.com/2024/05/25/predicine-to-present-10-liquid-biopsy-studies-at-asco-2024/</loc><lastmod>2024-06-03T04:02:37+00:00</lastmod></url><url><loc>https://predicine.com/2025/05/20/predicine-global-networking-reception-at-asco-annual-meeting-2025/</loc><lastmod>2025-05-20T00:38:37+00:00</lastmod></url><url><loc>https://predicine.com/2026/03/25/predicine-posters-at-asco-gu-2026/</loc><lastmod>2026-03-25T22:14:27+00:00</lastmod></url><url><loc>https://predicine.com/2026/10/15/predicine-liquid-biopsy-summit/</loc><lastmod>2026-10-20T14:18:54+00:00</lastmod></url><url><loc>https://predicine.com/2026/10/21/predicine-esmo-2026/</loc><lastmod>2026-10-21T20:45:01+00:00</lastmod></url></urlset>
